2023 Form 5500 filing — Acorda Therapeutics 401(K) Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241012161017NAL0024721425001) for Acorda Therapeutics 401(K) Plan, reported by Acorda Therapeutics, Inc. under EIN 13-3831168 and plan number 001. It reports 333 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).

EFAST2 acknowledgement
20241012161017NAL0024721425001
Filing year
2023
Form type
2
Plan sponsor
Acorda Therapeutics, Inc.
EIN
13-3831168
Plan number
001
Location
Pearl River, NY
Participants
333
Schedules available
Schedule H, Schedule C
Received date
not reported in the loaded dataset

Reported financial snapshot (2023)

Total assets (EOY)
$64,865,286
Total liabilities (EOY)
$0
Net assets (EOY)
$64,865,286
Employer contributions
$645,448
Participant contributions
$2,239,036
Total income / additions
$13,321,960
Benefits paid
$8,603,589
Administrative expenses
$45,911
Total expenses
$8,649,500
Net increase / (decrease)
$4,672,460
Schedule source
Schedule H

Reported service provider compensation (Schedule C)

Compensation reported on the 2023 filing
ProviderServiceDirect comp.Indirect comp.
Empower Life & Ann. Ins. Co Of NyRECORDKEEPER$45,662$0

Related Form 5500 pages